investigate Prevalence of lymphedema after breast neoplasm surgery

comparing Prevalence of lymphedema after Axillary Reverse Mapping by methylen blue or without methylen blue in patients with breast neoplasm

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200909048672N1

Enrollment

160

Registered

2020-12-06

Start date

2019-03-21

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: breast cancer. Condition 2: lymphedema. Malignant neoplasm of breast Postmastectomy lymphedema syndrome

Interventions

Intervention 1: first we inject methylen blue to patients in this group and with colored path that methylen blue makes , axillary lymph node mapping will be done. then using this mapping sentinel lymp

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: breast cancer SLNB+ARM±ALND candidate able to surgery

Exclusion criteria

Exclusion criteria: previous chemotherapy previous radiotherapy previous axilary surgery

Design outcomes

Primary

Measure	Time frame
Arm circumference. Timepoint: at the beginning and six month. Method of measurement: measuring with meter.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Eshraghi Samani

Esfahan University of Medical Sciences

dean@med.mui.ac.ir+98 31 3668 8597

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026